EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Durability of clinical benefit with Stanford Neuromodulation Therapy (SNT) in treatment-resistant depression

Andrew D Geoly, Katy H Stimpson, Flint M Espil, Brandon S Bentzley, Nolan R Williams

Brain Stimulation · 2025-05 · 18 (3) · 875-881

DOI: 10.1016/j.brs.2025.04.006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain Stimulation, 2025-05. Verfasst von Andrew D Geoly und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry & Behavioral Sciences, Stanford University, Palo Alto, CA, USA. Hauptthemen laut MEDLINE: Depressive Disorder, Treatment-Resistant, Transcranial Magnetic Stimulation. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Brain and Behavior Research Foundation, Mellam Family Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Depression, the leading cause of disability worldwide, is a chronic disease characterized by a relapsing-remitting course. Acute treatments such as electroconvulsive therapy, ketamine, and repetitive transcranial magnetic stimulation are often effective at initiating remission, but relapse to a major depressive episode is common without ongoing interventions. Stanford Neuromodulation Therapy (SNT) produces high rates of remission after five days of acute treatment; however, the duration of this remission following a single course of SNT in people suffering from treatment-resistant depression is unknown, which poses a significant limit on clinical decision-making. METHODS: Forty-six participants with treatment-resistant depression (TRD), received five days of SNT. Functional connectivity derived from resting-state functional MRI (fMRI) was used to individually target the region of the left dorsolateral prefrontal cortex most functionally anticorrelated with the subgenual anterior cingulate cortex. The 6-item Hamilton Depression Rating Scale (HDRS-6) was collected fortnightly for up to 24 weeks. Relapse was defined as two consecutive HDRS-6 scores of 5 or above. RESULTS: Seventy percent (32 of 46) of participants entered remission the week following treatment. After 12 weeks of treatment, 15 of 46 (33 %) participants remained in remission. Of the participants who entered remission, 15 of 32 (47 %) remained in remission. CONCLUSIONS: At 12 weeks, a subset of participants remained in remission, suggesting that the durability of SNT warrants further study. Comparisons with conventional rTMS should be interpreted cautiously given differences in study design, populations, and outcome measures.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Depressive Disorder, Treatment-ResistantTranscranial Magnetic StimulationHumansMaleFemaleMiddle AgedAdultMagnetic Resonance ImagingTreatment OutcomeGyrus Cinguli

Autor:innen und Institutionen

  • Department of Psychiatry & Behavioral Sciences, Stanford University, Palo Alto, CA, USA.
  • Department of Psychiatry & Behavioral Sciences, Stanford University, Palo Alto, CA, USA. Electronic address: nolanw@stanford.edu.

Förderung

  • Brain and Behavior Research Foundation
  • Mellam Family Foundation

Zitieren

APA

Geoly, A. D., Stimpson, K. H., Espil, F. M., Bentzley, B. S., & Williams, N. R. (2025). Durability of clinical benefit with Stanford Neuromodulation Therapy (SNT) in treatment-resistant depression. Brain Stimulation, 18(3), 875-881. https://doi.org/10.1016/j.brs.2025.04.006

Vancouver

Geoly AD, Stimpson KH, Espil FM, Bentzley BS, Williams NR. Durability of clinical benefit with Stanford Neuromodulation Therapy (SNT) in treatment-resistant depression. Brain Stimulation. 2025;18(3):875-881. doi:10.1016/j.brs.2025.04.006

BibTeX
@article{Geoly2025,
  author = {Geoly, Andrew D and Stimpson, Katy H and Espil, Flint M and Bentzley, Brandon S and Williams, Nolan R},
  title = {Durability of clinical benefit with Stanford Neuromodulation Therapy (SNT) in treatment-resistant depression},
  journal = {Brain Stimulation},
  year = {2025},
  volume = {18},
  number = {3},
  pages = {875--881},
  doi = {10.1016/j.brs.2025.04.006}
}
Kostenlos starten →